A conservative group behind state “right to try” laws says aggressive FDA reforms similar to those touted by GOP presidential candidate Ted Cruz are also needed to ease terminally ill patients’ access to unapproved but potentially life-saving therapies. The Goldwater Institute says FDA's drug approval regime needs to be revamped to include provisional approvals of new drugs and approval reciprocity with other industrialized nations. The group says current state and federal efforts don't incentivize drug manufacturers to make products being...